Cencora (COR) Stock

NYSE: CORGlobal healthcare company specializing in pharmaceutical distribution and related services, formerly known as AmerisourceBergen.

Cencora stock price chart

COR stock quote & key statistics

Cencora earnings per share

Income →
Earnings per share

Cencora revenue & net income

Income →
RevenueNet income

Cencora annual financials

Income statement →
Cencora revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$321.33B$1.55B$15.99
FY2024$293.96B$1.51B$13.76
FY2023$262.17B$1.75B$11.99
FY2022$238.59B$1.70B$11.02
FY2021$213.99B$1.54B$9.26

Fiscal year ending September 30. Source: company filings via EODHD.

About Cencora

Cencora, Inc., formerly known as AmerisourceBergen Corporation, operates through two core segments that serve the healthcare industry across the United States and internationally. Its U.S. Healthcare Solutions segment plays a pivotal role in distributing a wide array of pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies to various healthcare providers. These include acute care hospitals, retail pharmacies, mail order pharmacies, medical clinics, long-term care facilities, and other healthcare settings. The segment also offers comprehensive pharmacy management services, supply chain software solutions, packaging solutions, and specialized services such as clinical trial support and data analytics for biotechnology and pharmaceutical manufacturers. Moreover, it provides sales force services and distributes veterinary products to the companion and production animal markets.

Additionally, the U.S. Healthcare Solutions segment of Cencora, Inc. distributes plasma, injectable pharmaceuticals, vaccines, and other specialty products, catering to specialized healthcare providers including oncologists, hospitals, and dialysis clinics. Its International Healthcare Solutions segment operates primarily in Europe, where it engages in pharmaceutical wholesale distribution and offers related services. This segment also provides global commercialization services and specialized transportation and logistics solutions tailored for the biopharmaceutical industry.

Founded in 2001 and headquartered in Conshohocken, Pennsylvania, Cencora, Inc. exemplifies a commitment to enhancing healthcare delivery through its comprehensive range of services and solutions tailored for both domestic and international healthcare markets. The company continues to evolve its offerings to meet the diverse needs of healthcare providers and manufacturers globally, ensuring efficient distribution, logistics, and support services across the healthcare supply chain.

Cencora stock FAQ

What is the Cencora stock ticker symbol?

Cencora trades on the NYSE under the ticker symbol COR.

What sector and industry is Cencora in?

Cencora is classified in the Healthcare sector, Medical Distribution industry.

How many employees does Cencora have?

Cencora has about 47,000 full-time employees.

What were Cencora's revenue and earnings last fiscal year?

Cencora reported revenue of $321.33B and net income of $1.55B in fiscal 2025, with earnings per share of $15.99. Revenue grew 9.3% from the prior year.

Is Cencora in the S&P 500?

Yes. Cencora (COR) is a component of the S&P 500, the index of 500 leading U.S. companies widely used as a benchmark for the U.S. stock market.

Is Cencora in the Russell 1000?

Yes. Cencora (COR) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.

When did Cencora go public?

Cencora stock began trading on April 4, 1995.

S&P 500 Healthcare stocks

All S&P 500 →